https://doi.org/10.4103/2045-8932.83443 • https://www.jstor.org/stable/10.4103/2045-8932.83443 Copy URL Hatano S, Strasser T. Primary pulmonary hypertension. Report ...
Astrid E. Lammers, Ian Adatia, Maria Jesus del Cerro, Gabriel Diaz, Alexandra Heath Freudenthal, Franz Freudenthal, S. Harikrishnan, Dunbar Ivy, Antonio A. Lopes, J ...
In a phase 2 trial, selexipag, an oral selective IP prostacyclin-receptor agonist, was shown to be beneficial in the treatment of pulmonary arterial hypertension. In this event-driven, phase 3, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback